Hollencrest Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.51K Hold
96
﹤0.01% 858
2026
Q1
$8.32K Sell
96
-120
-56% -$11.5K ﹤0.01% 853
2025
Q4
$20.7K Buy
216
+120
+125% +$11.7K ﹤0.01% 706
2025
Q3
$9.14K Sell
96
-25
-21% -$2.3K ﹤0.01% 811
2025
Q2
$10.5K Hold
121
﹤0.01% 760
2025
Q1
$10.9K Hold
121
﹤0.01% 752
2024
Q4
$9.66K Sell
121
-616
-84% -$53.3K ﹤0.01% 799
2024
Q3
$66.4K Buy
737
+225
+44% +$18.9K ﹤0.01% 463
2024
Q2
$40.3K Sell
512
-63
-11% -$5.17K ﹤0.01% 544
2024
Q1
$50.1K Hold
575
﹤0.01% 491
2023
Q4
$47.4K Buy
575
+416
+262% +$31.7K ﹤0.01% 497
2023
Q3
$12.5K Hold
159
﹤0.01% 699
2023
Q2
$14K Sell
159
-175
-52% -$15.1K ﹤0.01% 717
2023
Q1
$26.9K Sell
334
-7,400
-96% -$603K ﹤0.01% 582
2022
Q4
$601K Sell
7,734
-48
-0.6% -$3.89K 0.07% 146
2022
Q3
$629K Buy
7,782
+102
+1% +$9.17K 0.08% 130
2022
Q2
$689K Sell
7,680
-559
-7% -$56.6K 0.08% 130
2022
Q1
$914K Sell
8,239
-21
-0.3% -$2.22K 0.08% 123
2021
Q4
$855K Sell
8,260
-365
-4% -$42.3K 0.07% 145
2021
Q3
$1.08M Hold
8,625
0.1% 110
2021
Q2
$1.07M Buy
8,625
+353
+4% +$44.3K 0.1% 112
2021
Q1
$977K Buy
8,272
+2,268
+38% +$266K 0.09% 118
2020
Q4
$704K Hold
6,004
0.07% 139
2020
Q3
$624K Buy
6,004
+164
+3% +$16.5K 0.07% 145
2020
Q2
$535K Buy
+5,840
New +$560K 0.07% 151
2015
Q1
Sell
-9,065
Closed -$654K 462
2014
Q4
$654K Sell
9,065
-384
-4% -$26.7K 0.09% 162
2014
Q3
$585K Buy
+9,449
New +$601K 0.08% 165

Other funds holding MDT

Hollencrest Capital Management's MDT Position: Q2 2026 in Review

Hollencrest Capital Management held its Medtronic (MDT) position steady in Q2 2026 at 96 shares worth $7.51K. The position accounts for ﹤0.01% of the portfolio, ranked #858.

Hollencrest Capital Management first reported a position in MDT in Q3 2014 and has held it in 27 quarters since. The position peaked at $1.08M in Q3 2021. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Hollencrest Capital Management held 96 shares of Medtronic worth $7.51K as of Q2 2026.
  • Hollencrest Capital Management left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up ﹤0.01% of Hollencrest Capital Management's portfolio in Q2 2026, its #858 holding.
  • Hollencrest Capital Management first reported a position in Medtronic in Q3 2014 and has held it in 27 quarters since.
  • Hollencrest Capital Management's Medtronic position peaked at $1.08M in Q3 2021.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.